References
- United Nations World Tourism Organization. Annual Report 2012. Available from: www.wtoelibrary.org/content/u34w53/?p=3f51253e91fc48c48dc3bdc99d3e675f&pi=2 [Last accessed 14 March 2014]
- Shoff WH, Behrman AJ, Shepherd SM. The Business expatriate. In: Jong E, Sanford C, editors. The travel and tropical medicine manual. 4th edition. Saunders; Philadelphia, PA, USA: 2008;281-91
- Chen LH, Leder K, Wilson ME. Business travelers. vaccination considerations of this population. Expert Rev Vaccines 2013;12:453-66
- YaleGlobal Online. Globalinc. An Atlas of the Multinational Corporation. Available from: http://yaleglobal.yale.edu/about/globalinc.jsp [Last accessed 14 March 2014]
- Feedbacq Blog. World Expat Population. Listed sources of data. World Bank, American Association of Residents Overseas, UK Border Agency, Migration Information Source, Wikipedia, International Organization for Migration, UN Department of Economic and Social Affairs, US Census Bureau. Available from: www.feedbacq.com/blog/world-expat-population-the- numbers/ [Last accessed 14 March 2014]; Listed sources of data. World Bank (www.worldbank.org), American Association of Residents Overseas (www.aaro.org), UK Border Agency (www.ukba.homeoffice.gov.uk), Migration Information Source (www.migrationinformation.org), Wikipedia (www.wikipedia.org), International Organization for Migration (www.iom.int), UN Department of Economic and Social Affairs (www.un.org/en/development/desa/population/index.shtml), US Census Bureau (www.census.gov)
- United Nations World Tourism Organization. Tourism Highlights 2012 Edition. Available from: www.wtoelibrary.org/content/x6k11g/?p=9b794bdfe8a34c01b0a05ada9e7b7353&pi=2 [Last accessed 14 March 2014]
- LaRocque RC, Rao SR, Lee J, et al. Global TravEpiNet. A national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations. and pre-travel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis 2012;54:455-62
- Global TravEpiNet. A national network of travel clinics across the United States sponsored by the CDC; collects data about individuals who travel internationally from the United States; co-ordinated by the Massachusetts General Hospital. Available from: www2.massgeneral.org/id/globaltravepinet/ [Last] [accessed 14 March 2014]
- Office of Travel and Tourism Industries, 2011 U.S. Travel and Tourism Statistics, Profile of U.S. Resident Travelers Visiting Overseas Destinations. 2011 Outbound. Available from: http://travel.trade.gov/outreachpages/outbound.general_information.outbound_overview.html [Last accessed 14 March 2014]
- The International Society of Travel Medicine. Available from: www.istm.org/ [Last accessed 14 March 2014]
- Schlagenhauf P, Santos-O’Connor F, Parola P. The practice of travel medicine in Europe. Clin Microbiol Infect 2010;16:203-8
- Gautret P, Freedman DO. Travel Medicine, a specialty on the move. Clin Microbiol Infect 2010;16:201-2
- Hatz C, Krause E, Grundmann H. Travel advice. a study among Swiss and German general practitioners. Trop Med Int Health 1997;2:6-12
- Sofarelli TA, Ricks JH, Anand R, et al. Standardized training in nurse model travel clinics. J Travel Med 2011;18:39-43
- Durham MJ, Goad JA, Neinstein LS, et al. A comparison of pharmacist travel-health specialists’ versus primary care providers’ recommendations for travel-related medications, vaccinations, and patient compliance in a college health setting. J Travel Med 2011;18:20-5
- GeoSentinel. A worldwide communication & data collection network of travel/tropical medicine clinics. Available from: www.istm.org/geosentinel/main.html [Last accessed 14 March 2014]
- TropNet. European Network for Tropical Medicine and Travel Health to collaborate research and surveillance of travel-related infectious and non-infectious diseases. Available from: www.tropnet.net/ [Last accessed 14 March 2014]
- EuroTravNet. European Travel and Tropical Medicine Network of the International Society of Travel Medicine (ISTM); ISTM member clinicians engage in detection, verification, management, and surveillance of communicable diseases that can be associated with travelling and specifically with tropical diseases; collaborates with GeoSentinel. Available from: www.istm.org/eurotravnet/main.html [Last accessed 14 March 2014]
- ECDC. European Centre for Disease Prevention and Control; it identifies, assesses, and communicates current and emerging threats to human health posed by infectious diseases; works in partnership with national health protection bodies across Europe. Available from: www.ecdc.europa.eu/en/Pages/home.aspx [Last accessed 14 March 2014]
- Public Health Agency of Canada. Available from: www.phac-aspc.gc.ca/index-eng.php [Last accessed 14 March 2014]
- Centers for Disease Control and Prevention (CDC). Available from: www.cdc.gov [Last accessed 14 March 2014]
- Gautret P, Schlagenhauf P, Gaudart J, et al. Multicenter EuroTravNet/Geosentinal study of travel-related infectious diseases in Europe. Emerg Infect Dis 2009;15:1783-90
- Lim P, Han P, Chen LH, et al. Expatriates ill after travel. Results from the Geosentinel Surveillance Network. BMC Inf Dis 2012.12:386. Available from: www.biomedcentral.com/1471-2334/12/386 [Last accessed 14 March 2014]
- International Health Regulations. Available from: www.who.int/ihr/en/ [Last accessed 14 March 2014]
- WHO. International travel and health 2012. The Green Book, formally WHO Yellow Book WHO; Geneva: 2012
- Ministry of Health, Kingdom of Saudi Arabia. Available from: www.moh.gov.sa/en/Hajj1432/Pages/AdviceBeforeHajj.aspx [Last accessed 14 March 2014]
- WHO International Travel and Health. The Green Book is available for purchase in print and PDF versions; “Chapter 6. Vaccine-preventable diseases and vaccines” is available in a modified PDF version. Available from: www.who.int/ith/chapters/ith2012en_chap6.pdf [Last accessed 14 March 2014] Electronic access to WHO information on specific vaccines. Available from: www.who.int/ith/en [Last accessed 14 March 2014]
- WHO. World Health Organization. Available from: www.who.int/en/ [Last accessed 14 March 2014]
- WHO. Immunization, Vaccines, Biologicals, WHO vaccine position papers. Introductory statement with link to list of position papers and routing immunization summary tables. Available from: www.who.int/immunization/documents/positionpapers_intro/en/index.html [Last accessed 14 March 2014]
- Brunette GW, Kozarsky PE, Cohen MJ, et al. The Yellow Book, CDC Health Information for International Travel 2014. Oxford; New York: 2014
- CDC Yellow Book Homepage. Available from: wwwnc.cdc.gov/travel/page/yellowbook-home-2014 Last accessed 14 March 2014
- CDC. Vaccines & Immunizations. Available from: www.cdc.gov/vaccines/ [Last accessed 14 March 2014]
- CDC. Vaccine Recommendations of the Advisory Committee for Immunization Practices (ACIP). Available from: www.cdc.gov/vaccines/hcp/acip-recs/index.html [Last accessed 14 March 2014]
- CDC. Essential electronic resources for the travel medicine practitioner. This is a thorough list of available and reliable online travel medicine resources. Available from: wwwnc.cdc.gov/travel/yellowbook/2014/appendices/appendix-b-essential-electronic-resources-for-the-travel-medicine-practitioner [Last accessed 14 March 2014]
- Public Health Agency of Canada Immunization & Vaccines. Available from: www.phac-aspc.gc.ca/im/index-eng.php [Last accessed 14 March 2014]
- Public Health England, The Green Book, immunization against infectious diseases. Available from: www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book [Last accessed 14 March 2014]
- Public Health England. Health Protection Agency, Infectious Disease Links. Available from: www.hpa.org.uk/Topics/InfectiousDiseases/InfectiousDiseasesLinks/ [Last accessed 14 March 2014]
- United Kingdom (UK). National Travel Health Network and Centre. Information for providers including destination information and ordering information for the “UK Yellow Book: Health Information for Overseas Travel”. Available from: www.nathnac.org/pro/index.htm [Last accessed 14 March 2014]
- NHS National Services Scotland, Health Protection Scotland, Travax. There is a fee charged for those who live outside Scotland and Wales. Available from: http://www.travax.nhs.uk/ [Last accessed 14 March 2014]
- Wynberg E, Sharyn T, Wendt JK, et al. Business Travelers’ risk perception of infectious diseases where are the knowledge gaps, and how serious are they? J Travel Med 2013;20:11-16
- McIntosh IB, Reed JM, Power KG. The impact of travel acquired illness on the world traveler and family doctor and the need for pre-travel health education. Scott Med J 1994;39:40-4
- Steffen R, Amitirigala I, Mutsch M. Health risks among travelers-Need for regular updates. J Travel Med 2008;15:45-6
- Serafin A. Developing and understanding between people. The key to global health. Travel Med Infect Dis 2010;8:180-3
- Aro AR, Vartti AM, Schreck M, et al. Willingness to take travel-related health risks- a study among Finnish tourists in Asia during the avian influenza outbreak. Int J Behav Med 2009;16:68-73
- Weber R, Schlagenhauf P, Amsler L, Steffan R. Knowledge, attitudes and practices of business travelers regarding malaria risk and prevention. J Travel Med 2003;10:219-24
- Van Herck K, Van Damme P, Castelli F, et al. Knowledge, attitudes and practices in travel-related infectious diseases. the European airport survey. J Travel Med 2004;11:3-8
- Connor BA, Patron DJ. Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler. J Occup Environ Med 2008;50:945-50
- Chen LH, Wilson ME, Davis X, et al. Illness in long-term travelers visiting GeoSentinel Clinics. Emerg Infect Dis 2009;15:1773-82
- Berg J, Breederveld D, Roukens AH, et al. Knowledge, attitudes, and practices toward malaria risk and prevention among frequent business travelers of a major oil and gas company. J Travel Med 2011;18:395-401
- Bettinger JA, Kozarsky PE. Defining short- and long-term travel. J Travel Med 2002;9:111
- Burkholder JD, Joines R, Cunningham-Hill M, Xu B. Health and well-being factors associated with international business travel. J Travel Med 2010;17(5):329-33
- Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ. Risk of malaria in British residents returning from malarious areas. BMJ 1990;300:499-503
- Banta JE, Jungblut E. Health problems encountered by the Peace Corps overseas. Am J Public Health Nations Health 1966;56:2121-5
- Freeman RJ, Mancuso JD, Riddle MS, et al. Systematic review and meta-analysis of TST conversion risk in deployed military and long-term civilian travelers. J Travel Med 2010;17:233-42
- Hillel O, Potasman I. Correlation between adherence to precautions issued by the WHO and diarrhea among long-term travelers to India. J Travel Med 2005;12:243-7
- Chen LH, Wilson ME, Schlagenhauf P. Prevention of malaria in long-term travelers. JAMA 2006;296:2234-44
- Leder K, Chen LH, Wilson ME. Aggregate travel vs. single trip assessment: arguments for cumulative risk analysis. Vaccine 2012;30:2600-4
- Eidex RB, McCarthy AE, Chen KH. “Long-Term Travelers & Expatriates.” Yellow Book Homepage. The Yellow Book. CDC Health Information for International Travel 2014. Available from: wwwnc.cdc.gov/travel/yellowbook/2014/chapter-8-advising-travelers-with-specific-needs/long-term-travelers-and-expatriates [Last accessed 14 March 2014]; or see Reference 30, pp 581-584
- Correia JD, Shafer RT, Patel V, et al. Blood and body fluid exposure as a health risk for international travelers. J Travel Med 2001;8:263-6
- Cockburn R, Newton PN, Agyarko EK, et al. The global threat of counterfeit drugs. why industry and governments must communicate the dangers. PLoS Med 2005;2(4):e100
- Bunn WB III. Risk and burden associated with the acquisition of viral hepatitis A and B in the corporate traveler. J Occup Environ Med 2008;50:935-44
- Patel D, Easmon CJ, Dow C, et al. Medical repatriation of British diplomats resident overseas. J Travel Med 2000;7:64-9
- Kollaritsch H, Que JU, Kunz C, et al. Safety and Immunogenicity of Live Oral Cholera and Typhoid Vaccines Administered Alone or in Combination with Antimalarial Drugs, Oral Polio Vaccine, or Yellow Fever Vaccine. J Infect Dis 1997;175:871-5
- Kroger AT, Strikas RA. “General Recommendations for Vaccination & Immunoprophylaxis.” Yellow Book Homepage. The Yellow Book, CDC Health Information for International Travel 2014. Available from: wwwnc.cdc.gov/travel/yellowbook/2014/chapter-2-the-pre-travel-consultation/general-recommendations-for-vaccination-and-immunoprophylaxis [Last accessed 14 March 2014]; or see Reference 11, pp 37-39 and 43-44
- CDC. General Recommendations on Immunization. Recommendations of the Advisor Committee on Immunization Practices. MMWR 2011.60(RR 2):1-60 Available from: www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm [Last accessed 14 March 2014]
- Hudson TW, Fortuna J. Overview of selected infectious disease risks for the corporate traveler. J Occup Environ Med 2008;50:924-34
- Chen LH, Wilson ME. The role of the traveler in emerging infections and magnitude of travel. Med Clin North Am 2008;92:1409-32
- Bhadelia N, Klotman M, Caplivski D. The HIV-positive traveler. Am J Med 2007;120:574-80
- Han P, Balaban V, Marano C. Travel characteristics and risk-taking attitudes in youths traveling to nonindustrialized countries. J Travel Med 2010;17:316-21
- Kotton CN, Hibberd PL; and the AST Infectious Diseases Community of Practice. Travel medicine and the solid organ transplant patient. Am J Transplant 2009;9:S273-81
- Boggild AK, Castelli F, Gautret P, et al. Vaccine preventable diseases in returned international travelers. results from the Geosentinel Surveillance Network. Vaccine 2010;28:7389-95
- CDC. Recommended adult immunization schedule - United States 2011. MMWR Morb Mortal Wkly Rep 2011;60(4):1-4
- Clemens R, Safary A, Hepburn A, et al. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995;171(Suppl 1):S44-9
- Thoelen S, Van Damme P, Leentvaar-Kuypers A, et al. The first combined vaccine against hepatitis A and B. an overview. Vaccine 1999;17:1657-62
- Connor BA, Blatter MM, Beran J, et al. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule. J Travel Med 2007;14:9-15
- Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007;357:1685-94
- McMahon BJ, Dentinger CM, Bruden D, et al. Antibody levels and protection after hepatitis B vaccine. results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009;200:1390-6
- Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55(RR-16):1-33
- Nielsen US, Petersen E, Larsen CS. Hepatitis B immunization coverage and risk behaviour among Danish travellers. are immunization strategies based on single journey itineraries rational? J Infect 2009;59:353-9
- Carter S, Horn K, Hart G, et al. The sexual behaviour of international travelers at two Glasgow GUM clinics. Int J STD AIDS 1997;8:336-8
- Ward BJ, Plourde P. Travel and sexually transmitted infections. J Travel Med 2006;13:300-17
- Leder K, Tong S, Weld L. Illness in travelers visiting friends and relatives. a review of the geographic risk. Clin Infect Dis 2006;43:1185-93
- Leder K, Black J, Obrien D, et al. Malaria in travelers. a review of the GeoSentinel surveillance network. Clin Infect Dis 2004;39:1104-12
- Ryan ET, Kain KC. Health advice and immunization for travelers. N Engl J Med 2000;342:1716-25
- WHO. Rabies biological products for passive immunization. Available at www.who.int/rabies/vaccines/other_rabies_biolog_product/en/ [Last accessed 14 March 2014] See also. Wilde H, Chomchey P, Punyaratabandhu P, Phanupak P, Chutivongse S. Purified equine rabies immune globulin. a safe and affordable alternative to human rabies immune globulin. Bull WHO 1989;67:731-736
- Gautret P, Parola P. Rabies vaccination for international travelers. Vaccine 2012;30:126-33
- Pandey P, Schlim DR, Cave W, Springer MF. Risk of possible exposure to rabies among tourists and foreign residents in Nepal. J Travel Med 2002;9:127-31
- Gautret P, Schwartz E, Shaw M, et al. Animal-associated injuries and related diseases among returned travelers. a review of the Geosentinel Surveillance Network. Vaccine 2007;25:2656-63
- Arguin PM, Krebs JW, Mandel E, et al. Survey of rabies preexposure and postexposure prophylaxis among missionary personnel stationed outside the United States. J Travel Med 2000;7:10-14
- Wijaya L, Ford L, Lalloo D. Rabies postexposure prophylaxis in a UK travel clinic. ten years experience. J Travel Med 2011;18:257-61
- Uwanyiligira M, Landry P, Genton B, et al. Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations. Clin Infect Dis 2012;55:201-5
- Gautret P, Wilder-Smith A. Vaccination against tetanus, diphtheria, pertussis and poliomyelitis in adult travelers. Travel Med Infect Dis 2010;8:155-60
- The current status of polio circulation. Available from: www.polioeradication.org [Last accessed 14 March 2014]
- Kulshammer M, Winke U, Frank M, et al. Poor immunity status against poliomyelitis in medical students. a semi-anonymous study. Med Microbiol Immunol 2013;202:63-5
- Connor B. “Traveler’s Diarrhea.” At Yellow Book Homepage. The Yellow Book. CDC Health Information for International Travel 2014. Available from: www.nc.cdc.gov/travel/yellowbook/2014/chapter-2-the-pre-travel-consultation/travelers-diarrhea [Last accessed 14 March 2014]
- Frank C, Faber MS, Askar M, et al. Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011. Euro Surveill 2011.16(21). Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19878 [Last accessed 14 March 2014]
- Connor BA. Sequellae of traveler’s diarrhea: focus on postinfectious irritable bowel syndrome. Clin Infect Dis 2005;41(S*):S577-86
- Stermer E, Lubezky A, Postasman I, et al. Is traveler’s diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006;43:898-901
- Connor BA, Riddle MS. Post-Infectious Sequelae of Travelers’ Diarrhea. J Travel Med 2013;20:303-12
- Smalligan RD, Lange WR, Frame JD, et al. The risk of viral hepatitis A, B, C, and E among North American missionaries. Am J Trop Med Hyg 1995;53:233-6
- Hamer DH, Ruffing R, Callaham MV, et al. Knowledge and use of measures to reduce health risks by corporate employees in western Ghana. J Travel Med 2008;15:237-42
- Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries. disease burden and implications for controls. Bull World Health Organ 2008;86:260-8
- Johnson KJ, Gallagher NM, Mintz ED, et al. From the CDC. new country-specific recommendations for pre-travel typhoid vaccination. J Travel Med 2011;18:430-3
- Lynch MF, Blanton EM, Bulens S, et al. Typhoid fever in the United States, 1999-2006. JAMA 2009;302:859-65
- Patel TA, Armstrong M, Morris-Jones SD, et al. Imported enteric fever. case series from the hospital for tropical diseases, London, United Kingdom. Am J Trop Med Hyg 2010;82:1121-6
- Kendall ME, Crim S, Fullerton K, et al. Travel-associated enteric infections diagnosed after return to the Unites States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009. Clin Infect Dis 2012;54(Suppl 5):S480-7
- Engels EA, Falagas ME, Lau J, et al. Typhoid fever vaccines. a meta-analysis of studies on efficacy and toxicity. BMJ 1998;316:110-16
- Ferreccio C, Levine MM, Rodriguez H, Contreras R. Comparative efficacy of two, three, or four doses of TY21a a live oral typhoid vaccine in enteric-coated capsules. a field trial in an endemic area. J Infect Dis 1989;159:766-9
- Gaffga NH, Tauxe RV, Mintz ED. Cholera. a new homeland in Africa? Am J Trop Med Hyg 2007;77:705-13
- CDC. Cholera associated with an international airline flight, 1992. MMWR Morb Mortal Wkly Rep 1992;41(8):134-5
- Sutton RG. An outbreak of cholera in Australia due to food served in flight on an international aircraft. J Hyg (Lond) 1974;72:441-51
- Svennerholm AM, Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev Vaccines 2008;7:795-804
- Shin S, Desai SN, Sah BK, Clemens JD. Oral vaccines against cholera. Clin Infect Dis 2011;52:1343-9
- Steinsland H, Valentiner-Branth P, Gjessing HK, et al. Protection from natural infections with enterotoxigenic Escherichia coli. longitudinal study. Lancet 2003;362:286-91
- Glenn GM, Villar CP, Flyer DC, et al. Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin. use of skin pretreatment to disrupt the stratum corneum. Infect Immun 2007;75:2163-70
- Wiedermann G, Kollaritsch H, Kundi M, et al. Double-blind, randomized placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B- subunit-inactivated whole cell vaccine against traveler’s diarrhea (preliminary report). J Travel Med 2000;7:27-9
- Sack DA, Shimko J, Torres O, et al. Randomized, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhoea of travelers to Guatemala and Mexico. Vaccine 2007;25:4392-400
- Walker RI, Steele D, Aguado T; Ad Hoc ETEC Technical Expert Committee. Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease. Vaccine 2007;25:2545-66
- Mckenzie R, Bourgeois AL, Engstrom F, et al. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults. Infect Immun 2006;74:994-1000
- Barry EM, Wang J, Wu T, et al. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model. Vaccine 2006;24:3727-34
- Khan S, Chatfield S, Stratford R, et al. Ability of SP12 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine 2007;25:4175-82
- Guerena-Burgueno F, Hall ER, Taylor DN, et al. Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect Immun 2002;70:1874-80
- Jentes ES, Poumerol G, Gershman MD, et al. The revised global yellow fever risk map and recommendations for vaccination, 2010. Consensus of the informal WHO working group on geographic risk for Yellow Fever. Lancet Infect Dis 2011;11:622-32
- Marfin AA, Eidex RS, Kozarsky PE. Yellow fever and Japanese Encephalitis vaccines: indications and complications. Infect Dis Clinics North Am 2005;19:151-68
- Hills SL, Griggs A, Fischer M. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg 2010;82:930-6
- Burchard GD, Caumes E, Connor BA, et al. Expert opinion on vaccination of travelers against Japanese Encephalitis. J Travel Med 2009;16:204-16
- Dubischar-Kastner K, Eder S, Buerger V, et al. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC 51. Vaccine 2010;28:5197-202
- Woolpert T, Staples JE, Faix DJ, et al. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Vaccine 2012;30:3090-6
- Erra E, Askling HH, Rombo L, et al. A single dose of Vero cell-derived Japanese encephalitis (JE) vaccine (IXIARO(R)) effectively boosts immunity in travellers primed with mouse brain-derived JE vaccines. Clin Infect Dis 2012;55:825-34
- Nasveld PE, Ebringer A, Elmes N, et al. Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine. randomized, double-blind, 5 year phase II study in healthy adults. Hum Vaccin 2010;6:1038-46
- Cohn A, MacNeil JR. Meningococcal Disease. The yellow book, CDC health information for international travel 2014. Oxford; New York: 2014
- CDC. Updated recommendations for use of meningococcal conjugate vaccines. Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2011;60(3):72-6
- Rendi-Wagner P. Advances in vaccination against tick-borne encephalitis. Expert Rev Vaccines 2008;7:589-96
- Demicheli V, Debalini MG, Rivetti A. Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev 2009(1):CD000977
- Leutscher PDC, Bagley SW. Health-related challenges in United States Peace Corps volunteers serving for two years in Madagascar. J Travel Med 2003;10:263-7
- Dahlgren A, DeRoo L, Avril J, et al. Health risks and risk-taking behaviors among International Committee of the Red Cross (ICRC) expatriates returning from humanitarian missions. J Travel Med 2009;16:382-90
- Croughs M, VanGompel A, de Boer E, et al. Sexual risk behavior of travelers who consulted a pretravel clinic. J Travel Med 2008;15:6-12
- Ansart S, Hochedez P, Perez L, et al. Sexually transmitted diseases diagnosed among traveler returning from the tropics. J Travel Med 2009;16:79-83
- Markowitz L, Dunne EF, Saraiya M, et al. Quadrivalent human papilloma vaccine. MMWR 2009;56:1-24
- Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59:630-2
- Barnett ED, Kozarsky PE, Steffen R. Vaccines for international travel. In: Plotkin SA, Orenstein WA, Offitt PA, editors. Vaccines. 6th edition. Saunders; Philadelphia: 2013;1270-89
- Pavli A, Maltezou HC. Malaria and travelers visiting friends and relatives. Travel Med Infect Dis 2010;8:161-8
- Behrens RH, Stauffer WM, Barnett ED, et al. Travel case scenarios as a demonstration of risk assessment of VFR travelers. Introduction to criteria and evidence-based definition and framework. J Travel Med 2010;17:153-62
- Crompton PD, Pierce SK, Miller LH. Advances and challenges in malaria vaccine development. J Clin Invest 2010;120:4168-78
- Greenwood B. Immunologic correlates of protection for the RTS,S candidate malaria vaccine. Lancet 2011;11:75-6
- Good MF. Our impasse in developing a malaria vaccine. Cell Mol Life Sci 2011;68:1105-13
- ClinicalTrials.gov. Available from: http://clinicaltrials.gov/show/NCT00866619
- Abdulla S, Oberholzer R, Omar J, et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 2008;359:2533-44
- Parekh FK, Moorthy VS. Plasmodium vivax vaccine research. Insights from Colombian studies. Am J Trop Med Hyg 2011;84(s2):1-3
- Freedman DO, Weld LH, Kozarsky P, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006;354:119-30
- Janisch T, Preiser W, Berger A, et al. Emerging viral pathogens in long-term expatriates II. Dengue virus. Trop Med Int Health 1997;2:934-40
- Halstead SB. Dengue. The syndromic basis to pathogenesis research. Inutility of the 2009 WHO Case Definition. Am J Trop Med Hyg 2013.88:212-15. Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC3583306/pdf/tropmed-88-212.pdf [Last accessed 14 March 2014]
- Thomas SJ. The necessity and quandaries of dengue vaccine development. J Infect Dis 2011;203:299-303
- Gibbons RV. Dengue conundrums. Int J Antimicrob Agents 2010;36(Suppl 1):S36-9
- Whitehorn J, Farrar J. Dengue. Br Med Bull 2010;95:161-73
- Trent D, Shin J, Hombach J, et al. WHO Working Group on Technical Specifications for manufacture and evaluation of dengue vaccines. Geneva, Switzerland. Vaccine 2010;28(52):8246-55
- Murrell S, Wu SC, Butler M. Review of dengue virus and the development of a vaccine. Biotechnol Adv 2011;29:239-47
- Ross TM. Dengue virus. Clin Lab Med 2010;30:149-60
- ClinicalTirals.gov. Available from: http://clinicaltrials.gov/ct2/show/NCT01134263
- Cobelens F, Van Deutekom H, Draayer-Janen I, et al. Association of tuberculin sensitivity in Dutch adults with history of travel to areas with a high incidence of tuberculosis. Clin Infect Dis 2001;33:300-4